Skip to content
VTRS Viatris Inc NASDAQ
11.94 USD 0.93% +0.11
OPEN 11.81
PREV CLOSE 11.83
DAY RANGE 12.02 - 11.78
VOLUME 12M
AVG. VOLUME 8.3M
52 WEEK RANGE 13.62 - 8.74
Interactive Brokers Logotype

Buy VTRS stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 14.2B
Enterprise value 31.2B
Trailing pe 238.79999
Forward pe 4.2795696
Peg ratio 4.2795696
Price to sales ttm 0.91914684
Price to book mrq 0.70049864
Enterprise to revenue 2.025
Enterprise to ebitda 6.431

Financials

Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.0035499998
Operating margin 0.13678999
Return on assets ttm 0.02786
Return on equity ttm 0.00263
Income statement
Revenue ttm 15.4B
Revenue per share ttm 12.853
Quarterly revenue growth -0.01
Gross profit ttm 6.4B
Ebitda 3.7B
Net income to common ttm 54.7M
Diluted eps ttm 0.05
Quarterly earnings growth yoy -0.009984520123839
Balance sheet
Total cash mrq 1.2B
Total cash per share mrq 0.997
Total debt mrq 18.4B
Total debt to equity mrq 89.758
Current ratio mrq 1.668
Book value per share mrq 17.045
Cash flow
Operating cash flow ttm 2.8B
Levered free cash flow ttm 1.1B

Stock statistics

Shares outstanding 1.2B
Float shares 1.2B
Avg 10 volume 8.3M
Avg 90 volume 11.1M
Shares short 38.5M
Short ratio 3.02
Short percent of shares outstanding 0.0372
Percent held by insiders 0.00352
Percent held by institutions 0.83408

Stock price summary

Fifty two week low 8.74
Fifty two week high 13.62
Fifty two week change 19.43
Beta 1.142
Day 50 ma 12.122
Day 200 ma 10.61525

Dividends and splits

Forward annual dividend rate 0.48
Forward annual dividend yield 0.04021784525546
Trailing annual dividend rate 0.96
Trailing annual dividend yield 0.080435690510921
5 year average dividend yield 0.89
Payout ratio 9.6
Dividend date 2024-03-18
Ex dividend date 2024-03-08
Last split factor 3-for-2 split
Last split date 2003-10-09

Viatris (VTRS) company profile

Viatris Inc. (NASDAQ: VTRS) is a healthcare company that develops, licenses, manufactures, markets, and distributes generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients. Some of the company’s popular markets include the Developed Markets, Greater China, JANZ, and Emerging Markets segments. The company’s drugs focus on infectious diseases and non-communicable diseases.